Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEFLUNOMIDE Cause Mean cell haemoglobin concentration abnormal? 12 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Mean cell haemoglobin concentration abnormal have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 0.0% of all adverse event reports for LEFLUNOMIDE.

12
Reports of Mean cell haemoglobin concentration abnormal with LEFLUNOMIDE
0.0%
of all LEFLUNOMIDE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Mean cell haemoglobin concentration abnormal From LEFLUNOMIDE?

Of the 12 reports.

Is Mean cell haemoglobin concentration abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does LEFLUNOMIDE Cause?

Drug ineffective (31,396) Rheumatoid arthritis (20,886) Pain (15,594) Drug intolerance (14,142) Joint swelling (13,026) Fatigue (11,959) Arthralgia (11,880) Rash (11,239) Contraindicated product administered (11,206) Abdominal discomfort (10,333)

What Other Drugs Cause Mean cell haemoglobin concentration abnormal?

ETANERCEPT (19) PREDNISONE (18) ADALIMUMAB (16) METHOTREXATE (16) TOFACITINIB (14) ECULIZUMAB (12) HERBALS\TURMERIC (12) NABILONE (12) ERGOCALCIFEROL (11) ATORVASTATIN (9)

Which LEFLUNOMIDE Alternatives Have Lower Mean cell haemoglobin concentration abnormal Risk?

LEFLUNOMIDE vs LEMBOREXANT LEFLUNOMIDE vs LENACAPAVIR LEFLUNOMIDE vs LENALIDOMIDE LEFLUNOMIDE vs LENIOLISIB LEFLUNOMIDE vs LENOGRASTIM

Related Pages

LEFLUNOMIDE Full Profile All Mean cell haemoglobin concentration abnormal Reports All Drugs Causing Mean cell haemoglobin concentration abnormal LEFLUNOMIDE Demographics